Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201320142015201620172018
Sales21 84820 24720 40520 89826 70127 754
Operating income (EBITDA)4 9743 8654 8505 0486 8237 536
Operating profit (EBIT)4 0462 8723 9794 0775 6236 292
Pre-Tax Profit (EBT)2 521-----
Net income2 5762 2844 4231 6663 5694 324
P/E ratio23,730,215,422,817,414,7
EPS ( $ )1,621,492,921,792,352,77
Dividend per Share ( $ )0,640,900,981,041,021,06
Yield1,67%2,00%2,18%2,54%2,50%2,60%
Reference price ( $ )38.3345.0244.9140.7640.7640.76
Announcement Date01/22/2014
12:44pm
01/29/2015
12:45pm
01/28/2016
12:31pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201320142015201620172018
Debt3 0863 7822 8764 12619 04916 930
Finance------
Operating income (EBITDA)4 9743 8654 8505 0486 8237 536
Leverage
(Debt/EBITDA)
0,62x0,98x0,59x0,82x2,79x2,25x
Capital Expenditure1 1451 0771 1101 1151 3041 280
Book Value Per Share (BVPS)16,3 $14,3 $14,4 $14,0 $21,2 $22,7 $
Cash Flow per Share2,11 $2,41 $1,97 $1,90 $3,72 $3,91 $
Announcement Date01/22/2014
12:44pm
01/29/2015
12:45pm
01/28/2016
12:31pm
---
Balance Sheet Analysis
Assessed data source :
© 2017 Thomson Reuters
Advertisement
Financial Ratios

Size 2016e 2017e
Capitalization 70 360 M$ -
Entreprise Value (EV) 74 485 M$ 89 408 M$
Valuation 2016e 2017e
P/E ratio (Price / EPS) 22,8x 17,4x
Capitalization / Revenue 3,37x 2,64x
EV / Revenue 3,56x 3,35x
EV / EBITDA 14,8x 13,1x
Yield (DPS / Price) 2,54% 2,50%
Price to book (Price / BVPS) 2,91x 1,92x
Profitability 2016e 2017e
Operating Margin (EBIT / Sales) 19,5% 21,1%
operating Leverage (Delta EBIT / Delta Sales) 1,02x 1,36x
Net Margin (Net Profit / Revenue) 7,97% 13,4%
ROA (Net Profit / Asset) 6,67% 7,33%
ROE (Net Profit / Equities) 14,7% 13,5%
Rate of Dividend 58,1% 43,3%
Balance Sheet Analysis 2016e 2017e
CAPEX / CA   5,34% 4,88%
Cash Flow / Sales 13,4% 20,5%
Capital Intensity (Assets / Sales) 1,20x 1,82x
Financial Leverage (Net Debt / EBITDA) 0,82x 2,79x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend